Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening
Status:
Completed
Trial end date:
2022-01-20
Target enrollment:
Participant gender:
Summary
The investigators have a current trial in China and the US which provides significant support
for the safety, cost-effectiveness, accuracy and efficiency of a high resolution
microendoscope (HRME)-guided approach in the hands of experienced clinicians. To improve
functionality, portability and broader use of this device by non-experts, the investigators
recently developed a prototype marHRME platform with an automated, augmented reality
(AR)-interpretation that provides an overlaid endoscopic + micro-endoscopic view,
facilitating diagnosis and biopsy targeting.
Phase:
Phase 2
Details
Lead Sponsor:
Anandasabapathy, Sharmila, M.D.
Collaborators:
Baylor College of Medicine University of Sao Paulo William Marsh Rice University